Anauran drops ear

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

lidocaine (lidocaine hydrochloride), neomycin (neomycin sulfate), polymyxin B (polymyxin B sulfate)

Доступна с:

Zambon S.P.A.

код АТС:

առկա չէ (S02)

ИНН (Международная Имя):

lidocaine (lidocaine hydrochloride), neomycin (neomycin sulfate), polymyxin B (polymyxin B sulfate)

дозировка:

4g/100ml+ 0.5g(375000IU)/100ml+ 1000000IU/100ml

Фармацевтическая форма:

drops ear

Штук в упаковке:

25ml glass bottle

Тип рецепта:

Prescription

Статус Авторизация:

Registered

Дата Авторизация:

2021-04-13

Характеристики продукта

1
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
ANAURAN EAR DROPS, SOLUTION
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
100 ml of solution contain:
ACTIVE INGREDIENTS
Polymyxin B sulfate
1000000
I.U.
Neomycin sulfate
(equivalent to base neomycin
0.500 g
375000 I.U.)
4.1
THERAPEUTIC INDICATIONS
Acute and chronic otitis.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
-
Adults: 4-5 drops, 2-4 times daily;
-
Children: 2-3 drops, 3-4 times daily.
Instill the drops, by means of the appropriate dropper, into the
external auditory canal while bending
the head to one side for some minutes.
The treatment duration depends on the promptness of the therapeutic
response,it is recommended not
use the medicine more than 10 consecutive days.
4.3
CONTRAINDICATIONS
ANAURAN is contraindicated:
-
in patients with hypersensitivity to Polymixin B sulfate, to Neomycin
sulfate and to Lidocaine
hydrochloride and any of the product ingredients and to other
chemically strictly related substances.
-
in patients who present the perforated tympanic membrane, due to the
risk of ototoxicity.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
The use, especially if prolonged, of topical preparations may cause
sensitization phenomena. In this
case it is necessary to discontinue the treatment and consult the
physician, in order to adopt an
adequate therapy.
In the presence of deep or resistant infections, it is appropriate to
integrate the local medication with
adequate antibiotic therapies by general route.
As for other antibiotic preparations, prolonged treatment may result
in superinfection by resistant
germs.
Lidocaine hydrochloride
4
g
3. PHARMACEUTICAL FORM
Ear drops.
4. CLINICAL PARTICULARS
2
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Incompatible with monomycin, streptomycin, gentamycin, amikacyn,
netilmycin due to
the increased ototoxic effect
4.6
PREGNANCY AND LACTATION
Pregnancy
There are no adequate and well controlled studies in pregnant women.
The preparation should be used in pregnant wome